COLUMBIA, Md., Dec. 1 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation announced that it intends to release the results of its fourth quarter and fiscal year 2006 on December 12, 2006, at approximately 4:00 p.m. Eastern Standard Time (EST). Following the release, at 4:45 p.m. EST Martek will hold a conference call to discuss its fourth quarter and fiscal year results with investors. The call is expected to be approximately one hour in duration. The conference call will also be available live via the Internet. All interested parties may listen to the call by visiting Martek's web site at http://investors.martek.com/.
An archive of the conference call will be available on Martek's website for thirty days. In addition, a recorded playback of the call will be available for one week and can be accessed by calling 800-633-8284 and entering pass code 21311211.
Martek Biosciences Corporation is a leader in the innovation and development of DHA omega-3 products that promote health and wellness through every stage of life. The Company produces life's DHA(TM), a sustainable and vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, beverages, infant formula, and supplements, and ARA (arachidonic acid), an omega-6 fatty acid, for use in infant formula. For more information on Martek Biosciences, visit http://www.martek.com/.
Contact: Kyle Stults
Investor Relations
(410) 740-0081
Cassie France-Kelly
Public Relations
(410) 740-0081
